Lunai Bioworks (LNAI) Interest Expenses (2012 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Interest Expenses of $108052.0 in Q1 2026, down 11.07% quarter-over-quarter from $121508.0 in Q4 2025, and down 42.73% on a YoY basis from $188685.0 in Q1 2025.
Lunai Bioworks (LNAI) Interest Expenses (2012 - 2026) Analysis & Trends
Lunai Bioworks' Interest Expenses history runs 14 years deep, the most recent figure standing at $108052.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 42.73% year-over-year to $108052.0; the TTM figure through Mar 2026 stood at $539988.0 (down 31.73% YoY), while the FY2025 annual figure was $725684.0, down 28.24% from the prior year.
- Interest Expenses was $108052.0 for Q1 2026 at Lunai Bioworks, down from $121508.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $303802.0 in Q1 2024 to a low of -$272762.0 in Q2 2022.
- Historically, Interest Expenses has averaged $141273.2 across 5 years, with a median of $122400.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses tumbled 379.69% in 2022, then surged 9784.4% in 2023.
- A 5-year view of Interest Expenses shows it stood at $2782.0 in 2022, then soared by 9784.4% to $274984.0 in 2023, then sank by 64.04% to $98891.0 in 2024, then advanced by 22.87% to $121508.0 in 2025, then declined by 11.07% to $108052.0 in 2026.
- The last three Interest Expenses figures came in at $108052.0 (Q1 2026), $121508.0 (Q4 2025), and $122400.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 108,052.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,052.00 |
| Mar 31, 2026 | 108,052.00 |
| Dec 31, 2025 | 121,508.00 |
| Dec 31, 2025 | 121,508.00 |
| Sep 30, 2025 | 122,400.00 |
| Sep 30, 2025 | 122,400.00 |
| Jun 30, 2025 | 188,028.00 |
| Jun 30, 2025 | 188,028.00 |
| Mar 31, 2025 | 188,685.00 |
| Mar 31, 2025 | 188,685.00 |
| Dec 31, 2024 | 98,891.00 |
| Dec 31, 2024 | 98,891.00 |
| Sep 30, 2024 | 250,080.00 |
| Sep 30, 2024 | 250,080.00 |
| Jun 30, 2024 | 253,265.00 |
| Jun 30, 2024 | 253,265.00 |
| Mar 31, 2024 | 303,802.00 |
| Mar 31, 2024 | 303,802.00 |
| Dec 31, 2023 | 274,984.00 |
| Dec 31, 2023 | 274,984.00 |